Solvents
Product Description
Merck
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:3
-
Employees:5000+
Company types
Categories
Merck
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:3
-
Employees:5000+
Company types
More Products from Merck (32)
-
Product API Contract Manufacturing
API Contract Manufacturing -
Product Drug Delivery Systems
Excipients / Formulation -
Product Tablet Filler-Binders
Excipients / Formulation -
Product Regulated Fine Chemicals
Fine Chemicals and Intermediates -
Product Advanced Intermediates
Fine Chemicals and Intermediates -
Product Custom Manufacturing / Exclusive Synthesis of Fine Chemicals
Custom Manufacturing
-
Product Glidants
Excipients / Formulation -
Product Sweetening Agents
Excipients / Formulation
-
Product Filtration / Separation / Purification
Pharmaceutical Technology, Laboratory and Analytical Equipment -
Product Substances for drug delivery (drug delivery compounds)
Merck offers wide range of pharmaceutical products and services which includes substances for drug delivery (drug delivery compounds). It belongs to process solutions products category. Contact us for more information. -
Product biomonitoring: microbiology
Merck offers wide range of pharmaceutical products and services which includes biomonitoring: microbiology. It belongs to lab solutions products category. Contact us for more information. -
Product Stem cells
Merck offers wide range of pharmaceutical products and services which includes stem cells. It belongs to bioscience products category. Contact us for more information.
Merck resources (3)
-
News Merck KGaA to design manufacturing process for first Nigerian vaccine plant through Innovative Biotech partnership
Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa -
Industry Webinar Streamlining Qualification of Custom Products in Biopharmaceutical Manufacturing: Solutions for Single-Use Systems and Cell Culture Media
The customization of single-use systems and cell culture media (CCM) presents significant opportunities for improving pharmaceutical manufacturing efficiencies, including reduced time, enhanced quality, and optimized resource utilization. However, the qualification of these custom products poses challenges, particularly regarding the systematic acquisition and evaluation of essential information.
This presentation will explore effective strategies for leveraging custom documentation to speed-up the qualification process of single-use assemblies and CCM. This includes: Key Criteria: Discussing the initial qualification criteria for selecting custom products Overcoming Obstacles: Evaluating common challenges and practical solutions in the qualification of custom single-use assemblies and CCM, Compliance Simplified: focus on quality and regulatory compliance documentation. -
News Merck KGaA doubles gene therapy capacity with opening of second Carlsbad CDMO facility
The new the 140,000-sq. ft facility will support commercialisation and industrialisation of viral vectors
